UFL1 triggers replication fork degradation by MRE11 in BRCA1/2-deficient cells
Nature Chemical Biology · 2024-12 · 20 (12) · 1650-1661
DOI: 10.1038/s41589-024-01611-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature Chemical Biology, online erschienen am 22.04.2024. Verfasst von Tian Tian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Geriatrics and Geriatrics Institute of Zhejiang Province, Affiliated Zhejiang Hospital, Zhejiang University School of Medi…. Hauptthemen laut MEDLINE: MRE11 Homologue Protein, DNA Replication, BRCA2 Protein, BRCA1 Protein. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China (National Science Foundation of China).
Abstract (Originalsprache)
The stabilization of stalled forks has emerged as a crucial mechanism driving resistance to poly(ADP-ribose) polymerase (PARP) inhibitors in BRCA1/2-deficient tumors. Here, we identify UFL1, a UFM1-specific E3 ligase, as a pivotal regulator of fork stability and the response to PARP inhibitors in BRCA1/2-deficient cells. On replication stress, UFL1 localizes to stalled forks and catalyzes the UFMylation of PTIP, a component of the MLL3/4 methyltransferase complex, specifically at lysine 148. This modification facilitates the assembly of the PTIP-MLL3/4 complex, resulting in the enrichment of H3K4me1 and H3K4me3 at stalled forks and subsequent recruitment of the MRE11 nuclease. Consequently, loss of UFL1, disruption of PTIP UFMylation or overexpression of the UFM1 protease UFSP2 protects nascent DNA strands from extensive degradation and confers resistance to PARP inhibitors in BRCA1/2-deficient cells. These findings provide mechanistic insights into the processes underlying fork instability in BRCA1/2-deficient cells and offer potential therapeutic avenues for the treatment of BRCA1/2-deficient tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Zhejiang Key Laboratory of Geriatrics and Geriatrics Institute of Zhejiang Province, Affiliated Zhejiang Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- The MOE Key Laboratory of Biosystems Homeostasis and Protection and Zhejiang Provincial Key Laboratory of Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University, Hangzhou, China.
- Center for Life Sciences, Shaoxing Institute, Zhejiang University, Shaoxing, China.
- Department of Cell Biology, and Department of General Surgery of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Cancer Center, Zhejiang University, Hangzhou, China.
- Zhejiang Key Laboratory of Geriatrics and Geriatrics Institute of Zhejiang Province, Affiliated Zhejiang Hospital, Zhejiang University School of Medicine, Hangzhou, China. liuting518@zju.edu.cn.
Förderung
- National Natural Science Foundation of China (National Science Foundation of China)
Zitieren
APA
Tian, T., Chen, J., Zhao, H., Li, Y., Xia, F., Huang, J., Han, J., & Liu, T. (2024). UFL1 triggers replication fork degradation by MRE11 in BRCA1/2-deficient cells. Nature Chemical Biology, 20(12), 1650-1661. https://doi.org/10.1038/s41589-024-01611-7
Vancouver
Tian T, Chen J, Zhao H, Li Y, Xia F, Huang J, et al. UFL1 triggers replication fork degradation by MRE11 in BRCA1/2-deficient cells. Nature Chemical Biology. 2024;20(12):1650-1661. doi:10.1038/s41589-024-01611-7
BibTeX
@article{Tian2024,
author = {Tian, Tian and Chen, Junliang and Zhao, Huacun and Li, Yulin and Xia, Feiyu and Huang, Jun and Han, Jinhua and Liu, Ting},
title = {UFL1 triggers replication fork degradation by MRE11 in BRCA1/2-deficient cells},
journal = {Nature Chemical Biology},
year = {2024},
volume = {20},
number = {12},
pages = {1650--1661},
doi = {10.1038/s41589-024-01611-7}
}
EUVIMED